We report 4 cases of Churg-Strauss syndrome (CSS) that occurred in pat
ients being treated with corticosteroids for a diagnosis of asthma. On
e patient had asthma, eosinophilia, and eosinophilic lymphadenopathy t
hat regressed with higher doses of corticosteroids, The second patient
had both eosinophilic tissue infiltration and symptoms suggestive of
vasculitis, while the remaining two patients had overt vasculitis; in
all three, vasculitis developed after tapering or discontinuation of c
orticosteroid therapy. Two patients died of their disease, We have lab
elled these cases as formes frustes CSS. Our observations suggest that
some cases of CSS may be partially or totally suppressed by corticost
eroid therapy for asthma for very long periods and that asthmatic subj
ects maintained on low-dose corticosteroid therapy or asthmatic subjec
ts whose corticosteroid doses are being tapered should be carefully mo
nitored for the development of CSS signs and symptoms.